Hylenex Recombinant and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Hylenex Recombinant and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase
Brand name: Amphadase, Hylenex, Vitrase, Wydase, Hydase
Synonyms: Hyaluronidase (injection), Hyaluronidase
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hylenex Recombinant-Lithium ER
- Hylenex Recombinant-Lithium Oral Solution
- Hylenex Recombinant-Lithium Salts
- Hylenex Recombinant-Lithium Syrup and Oral Solution
- Hylenex Recombinant-Lithobid
- Hylenex Recombinant-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Hylorel
- Lithium Controlled-Release and Extended-Release Tablets-Hymovis
- Lithium Controlled-Release and Extended-Release Tablets-Hyolev MB
- Lithium Controlled-Release and Extended-Release Tablets-Hyolev MB Tablets
- Lithium Controlled-Release and Extended-Release Tablets-HyoMax
- Lithium Controlled-Release and Extended-Release Tablets-HyoMax-DT